文献速递妇产影像介入MRUS

微泡造影剂声诺维增强高强度聚焦超声治疗子宫腺肌症的临床实用性

Clinical Usefulness of the Microbubble Contrast Agent SonoVue in Enhancing the Effects of High-Intensity Focused Ultrasound for the Treatment of Adenomyosis.
PubMed 文献 · J Ultrasound Med · 2018-04-24

研究纳入2015年8月至2017年4月评估的102例子宫腺肌症患者,随机分为A组(注射声诺维后1分钟开始HIFU)和B组(注射后10分钟开始),比较两组疗效与安全性。结果显示两组灰度大范围改变、无灌注体积及消融率相似,A组辐照时间、平均功率、总能量及能量效率因子更低,术中疼痛等不良事件发生率更低。

要点

  • 注射声诺维后1分钟启动HIFU较10分钟启动可缩短至灰度大范围改变的辐照时间并降低总能量。
  • 两组无灌注体积与消融率相似,提示早期启动不降低消融效果。
  • A组术中治疗区疼痛、腿痛及坐骨神经或臀部疼痛发生率更低。

核心结论

  • 总体而言,注射声诺维后1分钟开始HIFU辐照可通过空化和加热增强消融且安全,早期灰度大范围改变、较低总能量和降低的平均功率是潜在安全性因素。

研究设计与样本

  • 随机对照研究,共纳入2015年8月至2017年4月评估的102例子宫腺肌症患者,随机分为1分钟组(A组)和10分钟组(B组),两组分别在注射声诺维后1分钟和10分钟开始HIFU,所有患者HIFU治疗前后均行磁共振成像扫描。

关键影像表现/征象

  • 两组灰度大范围改变发生率、无灌注体积和消融率相似(P > .05)。
  • A组至灰度大范围改变的辐照时间较B组缩短(P < .05)。
  • A组平均功率、总能量和能量效率因子均低于B组(均P < .05)。

临床应用与阅片要点

  • 注射声诺维后1分钟启动HIFU辐照可增强空化和加热消融,并降低平均功率与总能量。
  • A组术中治疗区疼痛、腿痛及坐骨神经或臀部疼痛发生率显著低于B组(P < .05)。
  • 两组多数围术期不良事件及全部术后不良事件发生率相似(P > .05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the clinical usefulness of the microbubble contrast agent SonoVue in enhancing high-intensity focused ultrasound (HIFU) for the treatment of adenomyosis.

METHODS: A total of 102 patients with adenomyosis, assessed from August 2015 to April 2017, were randomly divided into 1-minute (A) and 10-minute (B) groups, respectively. In groups A and B, HIFU started 1 minute and 10 minutes, respectively, after SonoVue injection. All patients underwent a magnetic resonance imaging scan before and after HIFU treatment.

RESULTS: The occurrence rates of massive gray scale change, nonperfused volume, and fractional ablation were similar in both groups (P > .05). Meanwhile, sonication time to massive gray scale change was reduced in group A compared with group B (P < .05). In addition, mean power, total energy, and energy efficiency factor were lower in group A than group B (all P < .05). The incidence rates of most perioperative and all postoperative adverse events were similar in both groups (P > .05). The incidence rates of pain in the treated region, leg pain, and sciatic or buttock pain during HIFU were substantially lower in group A than group B (P < .05).

CONCLUSIONS: Overall, starting HIFU sonication at 1 minute after SonoVue injection enhances HIFU ablation by cavitation and heating and is safe. Early massive gray scale change, lower total energy, and reduced mean power are potential safety factors.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Jingqi W, Lu Z, Jun Z, et al. Clinical Usefulness of the Microbubble Contrast Agent SonoVue in Enhancing the Effects of High-Intensity Focused Ultrasound for the Treatment of Adenomyosis. J Ultrasound Med. 2018. PMID: 29689636. doi:10.1002/jum.14638

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。